Winton Group’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-8,777
Closed -$2.08M 1051
2021
Q4
$2.08M Buy
8,777
+2,588
+42% +$605K 0.13% 216
2021
Q3
$1.44M Buy
6,189
+566
+10% +$119K 0.08% 324
2021
Q2
$1.16M Buy
5,623
+1,749
+45% +$360K 0.06% 453
2021
Q1
$796K Sell
3,874
-654
-14% -$138K 0.05% 599
2020
Q4
$971K Sell
4,528
-9,079
-67% -$1.76M 0.07% 418
2020
Q3
$2.49M Sell
13,607
-6,406
-32% -$1.21M 0.08% 426
2020
Q2
$3.69M Buy
20,013
+15,481
+342% +$3.07M 0.1% 350
2020
Q1
$914K Buy
+4,532
New +$872K 0.02% 837
2018
Q3
Sell
-5,315
Closed -$1.56M 1057
2018
Q2
$1.56M Sell
5,315
-4,214
-44% -$1.15M 0.04% 355
2018
Q1
$2.4M Sell
9,529
-18,290
-66% -$4.3M 0.07% 302
2017
Q4
$6.01M Buy
+27,819
New +$5.63M 0.17% 184

Other funds holding ICUI

Winton Group's ICUI Position: Q1 2022 in Review

Winton Group sold out of ICU Medical (ICUI) in Q1 2022, closing a stake of 8,777 shares — an estimated $2.08M sold.

Winton Group first reported a position in ICUI in Q4 2017 and held it in 11 quarters. The position peaked at $6.01M in Q4 2017. 295 funds tracked by Wall St. Rank hold ICUI as of Q1 2022.

  • Winton Group reported no remaining ICU Medical position as of Q1 2022 after selling out during the quarter.
  • Winton Group sold 8,777 ICU Medical shares in Q1 2022, an estimated $2.08M.
  • Winton Group first reported a position in ICU Medical in Q4 2017 and held it in 11 quarters.
  • Winton Group's ICU Medical position peaked at $6.01M in Q4 2017.
  • 295 funds tracked by Wall St. Rank held ICU Medical as of Q1 2022.

Based on Winton Group's 13F filing for Q1 2022, filed 11 May 2022.